SAM
PCRX icon

Shell Asset Management’s Pacira BioSciences PCRX Stock Holding History

Shell Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$26K Sell
1,014
-772
-43% -$19K ﹤0.01% 1002
2025
Q2 		$43K Sell
1,786
-171
-9% -$4.31K ﹤0.01% 1170
2025
Q1 		$49K Sell
1,957
-74
-4% -$1.77K ﹤0.01% 1152
2024
Q4 		$38K Hold
2,031
– – ﹤0.01% 1204
2024
Q3 		$31K Buy
+2,031
New +$34.7K ﹤0.01% 1213
2024
Q1 		$53K Sell
1,858
-246
-12% -$7.56K ﹤0.01% 1151
2023
Q4 		$71K Sell
2,104
-635
-23% -$18.6K ﹤0.01% 1126
2023
Q3 		$84K Sell
2,739
-42
-2% -$1.51K ﹤0.01% 1119
2023
Q2 		$111K Sell
2,781
-16
-0.6% -$661 ﹤0.01% 1101
2023
Q1 		$114K Sell
2,797
-10
-0.4% -$398 ﹤0.01% 1069
2022
Q4 		$108K Sell
2,807
-604
-18% -$29.4K ﹤0.01% 1137
2022
Q3 		$181K Sell
3,411
-885
-21% -$49.2K 0.01% 1047
2022
Q2 		$250K Buy
4,296
+1,000
+30% +$65.5K 0.01% 1051
2022
Q1 		$252K Sell
3,296
-487
-13% -$32.5K 0.01% 1106
2021
Q4 		$228K Buy
3,783
+12
+0.3% +$662 ﹤0.01% 1174
2021
Q3 		$211K Sell
3,771
-160
-4% -$9.22K ﹤0.01% 1187
2021
Q2 		$239K Buy
3,931
+2,518
+178% +$159K ﹤0.01% 1183
2021
Q1 		$99K Buy
+1,413
New +$101K ﹤0.01% 1290

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Shell Asset Management's PCRX Position: Q3 2025 in Review

Shell Asset Management reduced its Pacira BioSciences (PCRX) stake by 43% in Q3 2025, selling an estimated $19K and leaving 1,014 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #1002.

Shell Asset Management first reported a position in PCRX in Q1 2021 and has held it in 18 quarters since. The position peaked at $252K in Q1 2022. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2025.

  • Shell Asset Management held 1,014 shares of Pacira BioSciences worth $26K as of Q3 2025.
  • Shell Asset Management sold 772 Pacira BioSciences shares in Q3 2025, an estimated $19K.
  • Pacira BioSciences made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #1002 holding.
  • Shell Asset Management first reported a position in Pacira BioSciences in Q1 2021 and has held it in 18 quarters since.
  • Shell Asset Management's Pacira BioSciences position peaked at $252K in Q1 2022.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.